ABN Newswire is a business newswire and press release distribution service for listed companies on stock exchanges globally. ABN Newswire distributes company announcements to the professional platforms, finance portals and syndicates important corporate news to a wide variety of news aggregators and financial news systems.
UK, Feb 1, 2008 - (ABN Newswire) - David Laskow-Pooley to Head EU Region of Leading Clinical Supplies Company
CRICKHOWELL, POWYS, WALES--(Marketwire - February 01, 2008) - David Laskow-Pooley, MRPharmsS, QP, former CEO of Surface Therapeutics, has joined Bilcare Global Clinical Supplies (Europe) Ltd. (www.BilcareGCS.com) as President. Laskow-Pooley will head the EU Region of Bilcare GCS, a global firm which also has offices in the US, India and Singapore. A subsidiary of Bilcare Limited, headquartered in Pune, India, Bilcare GCS is a leading provider of the packaging and global distribution of clinical trial materials. "David is a tremendous addition to our team," said Bilcare Limited Chairman and Managing Director, Mohan Bhandari. "His wealth of global industry experience and the depth of his expertise is a perfect fit for our expanding European operation."
Laskow-Pooley has 30 years of experience in all aspects of the discovery, development and commercialization of Pharmaceutical and healthcare products. He has had a distinguished career in the industry working for a number of pharmaceutical and life sciences companies including GlaxoSmithKline, Abbott, Invitrogen and Amersham in Europe, the US and Japan, and OSI Pharmaceuticals. He was previously CEO of Surface Therapeutics Ltd., a start up company spun out of the University of Oxford which recently sold to Serentis Ltd.
Laskow-Pooley has a degree in pharmacy, specializing in industrial pharmacy and chemical engineering and is a registered Qualified Person. He is chair of the steering group of the Oxfordshire Bioscience Network and an independent Governor of Oxford Brookes University.
Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with clinical trial materials support, services and complete project management. Our services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical trial materials (CTM) satisfy a broad range of requirements; from pre-formulation research and development, analytical services and clinical supplies packaging and labeling, to IVRS, controlled temperature (cold and frozen chain) CTM storage, distribution worldwide, and returns and destructions accountability.
For more information about Bilcare Global Clinical Supplies, please visit our website at www.BilcareGCS.com.
Media Contacts: Vincent Santa Maria, CPA President Bilcare Global Clinical Supplies, Americas Phone: 610-422-3180 Fax: 610-935-4321 direct-gcs@Bilcare.com
Corporate Information Contact: Jaydip Chowdhury Head Corporate Communications Jaydip.Chowdhury@Bilcare.com